98419j10 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from 98419j10. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In 98419j10 Today - Breaking & Trending Today

XOMA's (XOMA) Buy Rating Reiterated at HC Wainwright

HC Wainwright reissued their buy rating on shares of XOMA (NASDAQ:XOMA – Free Report) in a research report released on Wednesday, Benzinga reports. HC Wainwright currently has a $74.00 price target on the biotechnology company’s stock. Separately, SVB Leerink assumed coverage on shares of XOMA in a report on Monday, April 29th. They set an […] ....

United States , Asia Pacific , Free Report , Get Free Report , Financial Markets , Financial Market , Nasdaq Xoma , Reiterated Rating , Hc Wainwright ,

Q1 2024 Earnings Forecast for XOMA Co. Issued By Leerink Partnrs (NASDAQ:XOMA)

XOMA Co. (NASDAQ:XOMA – Free Report) – Research analysts at Leerink Partnrs issued their Q1 2024 earnings per share (EPS) estimates for XOMA in a report issued on Monday, April 29th. Leerink Partnrs analyst D. Risinger anticipates that the biotechnology company will post earnings of ($0.85) per share for the quarter. Leerink Partnrs has a […] ....

United States , Asia Pacific , Leerink Partnrs , Exchange Commission , Xoma Co , Free Report , Get Free Report , Financial Markets , Financial Market , Nasdaq Xoma , Earnings Estimates ,

XOMA (NASDAQ:XOMA) Earns "Outperform" Rating from Leerink Partnrs

Leerink Partnrs reiterated their outperform rating on shares of XOMA (NASDAQ:XOMA – Free Report) in a report issued on Monday, Zacks.com reports. Leerink Partnrs also issued estimates for XOMA’s Q1 2024 earnings at ($0.85) EPS, Q2 2024 earnings at ($0.79) EPS, Q3 2024 earnings at ($0.54) EPS, Q4 2024 earnings at ($0.69) EPS, FY2024 earnings […] ....

United States , Leerink Partnrs , Asia Pacific , Company Profile , Exchange Commission , Free Report , Get Free Report , Financial Markets , Financial Market , Nasdaq Xoma , Reiterated Rating ,

XOMA (NASDAQ:XOMA) Receives New Coverage from Analysts at SVB Leerink

Stock analysts at SVB Leerink initiated coverage on shares of XOMA (NASDAQ:XOMA – Get Free Report) in a research report issued on Monday, Briefing.com reports. The firm set an “outperform” rating and a $40.00 price target on the biotechnology company’s stock. SVB Leerink’s price target points to a potential upside of 57.42% from the company’s […] ....

United States , Asia Pacific , Exchange Commission , Company Profile , Stonepine Capital Management , Get Free Report , Capital Management , Free Report , Nasdaq Xoma , Initiated Coverage , Svb Leerink Llc ,

XOMA's (XOMA) Buy Rating Reiterated at HC Wainwright

HC Wainwright reissued their buy rating on shares of XOMA (NASDAQ:XOMA – Free Report) in a report issued on Thursday morning, Benzinga reports. They currently have a $74.00 target price on the biotechnology company’s stock. XOMA Stock Up 0.2 % XOMA stock opened at $25.41 on Thursday. The firm has a market cap of $295.77 […] ....

United States , Asia Pacific , Securities Exchange Commission , Barclays Plc , Company Profile , Free Report , Get Free Report , Nasdaq Xoma , Reiterated Rating , Hc Wainwright ,